Advancing and Realizing Precision Medicine
international
Laboratory of
Advanced
Creations
iLAC provides disease diagnosis based on scientific evidence using cutting-edge genome analysis systems.
Cancer is a genetic disease caused by various factors.
Our company aims to advance and realize “Precision Medicine”—which leads to the selection of optimal treatments and drugs for each individual—through collaborative research with leading domestic and international research institutions.
We conduct drug target discovery for cancers, congenital metabolic disorders, and intractable diseases; biomarker discovery for conditions such as dementia and cardiovascular diseases; and provide clinical research support for development studies by domestic and international pharmaceutical companies.
We collaborate with corporations and medical institutions to conduct research and development in the field of femtech and perform whole-genome analysis in genomic screening, with the aim of contributing to disease prevention and health management.
We support molecular cohort studies and advance cutting-edge AI analysis through omics analysis (genome, transcriptome, epigenome, proteome, metabolome) and the development of novel algorithms.
Partner companies creating new value together under one roof.
